Sanofi licenses fourth NK cell engager from Innate Pharma – Pharmaceutical Technology
Share this article Sanofi has already licensed four programmes from Innate Pharma – with two of those in Phase II clinical trials. Image credit: Shutterstock/JHVEPhoto.